Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy have?

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy has 149 citations in the OpenAlex counts ScholarIQ stores.

When was Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy published?

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy has 2021 year in the ScholarIQ index.

What is the open-access status of Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy has gold oa status in the ScholarIQ index.

What is the DOI of Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?

The DOI for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is on the source record.

What is the PMID of Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?

The PMID for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is on the source record.

What is the OpenAlex record for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?

The OpenAlex for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is on the source record.